Texas Oncology - Sammons Cancer Center — Dallas, Texas

Texas Oncology - Sammons Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology - Sammons Cancer Center has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Gradalis, Inc., NovoCure GmbH.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Sammons Cancer Center?

Texas Oncology - Sammons Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Sammons Cancer Center conducted?

Texas Oncology - Sammons Cancer Center has 8 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Texas Oncology - Sammons Cancer Center accredited by Crixeo Health?

Yes — Texas Oncology - Sammons Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - Sammons Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.